AstraZeneca PLC is 12.4x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($286.27 B vs $23.17 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | UTHR | AZN |
|---|---|---|
| Market cap | $23.17 B | $286.27 B |
| US-listed rank | #563 | #49 |
| Revenue (latest FY) | $3.18B | - |
| Net income (latest FY) | $1.33B | - |
| Net margin | 41.9% | - |
| P/E (trailing FY) | 17.4 | - |
| SEC filings | 4,203 | 1,004 |
AstraZeneca PLC is 12.4x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($286.27 B vs $23.17 B).
Full pages: UNITED THERAPEUTICS Corp and AstraZeneca PLC, or browse the full rankings.